(January 31st, 2022) Aker BioMarine, the world’s leading supplier of krill, has large growth ambitions in Asia. To better serve its business in the region, the company has established an office in Tokyo, Japan.
Aker BioMarine has for over a decade sold its high-quality krill oil product Superba in Japan, which is one of the largest health-related food markets in the world. As the demand for krill products is growing, the company has strengthened its local team with additional sales and marketing functions.
“We see Japan as an important market for Aker BioMarine. We recognize the increasing demand for high-quality nutraceutical ingredients from sustainable sources in the country makes us well equipped to serve businesses looking to bring new value to their customers. We are excited to do business in Japan and committed to better aiding consumers in the Japanese market”, says Matts Johansen, the Chief Executive Officer in Aker BioMarine.
Superba krill oil is a unique formula extracted from Antarctic krill to deliver essential omega-3 (EPA & DHA), choline, phospholipids and, astaxanthin with proven effects to improve human health. Last year, Aker BioMarine sold more than 1.6 billion doses of Superba krill worldwide, improving the health of millions of people.
“I am looking forward to strengthening the team to further support our customers in Japan. By working closely with some of the best companies in the nutraceuticals market, we can ensure that consumers across the country have access to krill oil for their overall health“, says Anette Yamamoto-Hansen, Representative Director of Aker BioMarine Japan KK.
“Aker BioMarine is part of Aker ASA, an industrial investment company with over 180 years of history. People in Norway have a long tradition of taking care of their health through the daily intake of marine Omega-3s from various sources, such as krill oil. By establishing a subsidiary in Japan, we hope that Aker BioMarine’s health food ingredients can contribute positively to the vigor of the Japanese people. We welcome Aker BioMarine’s subsidiary to the Norway-Japan community and wish them the best of luck”, says Svend Haakon Kristensen, Chair Person of the Norwegian Chamber of Commerce in Japan.
About Aker BioMarine
Aker BioMarine is the world’s leading supplier of krill, developing products for pharma, consumer health and animal nutrition. Listed on Oslo Stock Exchange, the company develops krill-based ingredients for pharmaceutical, nutraceutical (Superba®, NKO® and K·REAL®), aquaculture (QRILL™ Aqua), and animal feed applications (QRILL™ Pet), including INVI™, a highly-concentrated protein isolate, and LYSOVETA™, a targeted transporter of EPA and DHA from krill. Aker BioMarine’s fully transparent value chain stretches from sustainable krill harvesting in pristine Antarctic waters through its Montevideo logistics hub, Houston production plant, and to customers around the world. The company’s strong focus on sustainability inspired the launch of AION by Aker BioMarine, a circularity company dedicated to helping companies to recycle and reuse waste. Read more: www.akerbiomarine.com
For more information, please contact:
Communications Director, Aker BioMarine ASA
+47 934 33 087